Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Genmab A/S
Today
Create an eToro account to buy GMAB.CO stock on a secure, user-friendly, multi-asset trading platform.
Buy Genmab A/S
Buy Genmab A/S
Genmab A/S GMAB.CO
Buy GMAB.CO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Genmab A/S News

Stocks-GMAB.CO-Genmab A/S

Genmab A/S GMAB.CO

$1,350.4726.47(2%)(1D)
• Copenhagen Stock Exchange • in DKK

GMAB.CO Stock Price Chart

‎-16.82‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Genmab A/S share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Genmab A/S share price today is 1,350.47, reflecting a ‎2‎% change over the last 24 hours and ‎-4.01‎% over the past week. The current market capitalization of GMAB.CO is 12.17B with an average volume in the last three months of 146262.82. The stock has a P/E ratio of 10.81 and a dividend yield of 0%. With the stock’s beta sitting at 0.48
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$12.17B
Day’s Range
i
Shows the high and low prices of the day.
1298.05 - 1649.02
52W Range
i
Shows the high and low prices of the last year.
1298.05 - 2701.94
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
146262.82
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
10.81
Revenue
i
The total income generated by this company’s goods and services last year.
$21.53B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$1325
EPS
i
A company’s total earnings divided by the number of shares it has issued.
122.59
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.48
What Is Genmab A/S?
Founded in 1999, Genmab A.S. is a biotechnology company with a mission to fight cancer and better the lives of cancer sufferers. The company creates and develops antibody therapeutics for the treatment of cancer through biotechnology research and solutions. It is based in Copenhagen, Denmark, with offices and research outfits in the United States, the Netherlands, and Japan. This company endeavours to produce treatments in line with natural antibody defences and redefine therapy approaches to cancer.

As a dual-listed company, Genmab is indentified under the ticker GMAB on the Copenhagen Stock Exchange (CSE). As part of its investor relations policy, this company aims to keep investors informed and up-to-date with developments affecting its financial profile. Trading in the healthcare sector, the GMAB share price averaged 2,300 DKK on 4 December 2020. Genmab projected revenue of approximately 4bn DKK for 2020, which mainly consists of royalties and reimbursements.

Genmab is partnered with prominent pharmaceutical companies to further its research and production goals. These companies include Janssen Biotech Inc., Novartis Pharma A.G., Amgen Inc., and Tempus. The United States Food and Drug Administration (FDA) has to-date green-flagged several prominent Genmab therapeutics, including Daratumumab, Ofatumumab, and Teprotumumab. This company has a broad product pipeline, which includes clinical and non-clinical therapeutics.

Learn more about GMAB stock by adding this item to your eToro watchlist, or invest now.
Buy GMAB.CO

How can I buy Genmab A/S stocks?

To purchase Genmab A/S:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Genmab A/S (GMAB.CO) page and place an order to buy Genmab A/S.
Buy GMAB.CO
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Genmab A/S
Invest in Genmab A/S
Today
Create an eToro account to buy GMAB.CO stock on a secure, user-friendly, multi-asset trading platform.
Buy GMAB.CO

FAQ

The current price of GMAB.CO is 1,350.47.
The average price target for Genmab A/S is 1,350.47. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Genmab A/S based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Genmab A/S is 12.17B
Daily Movers
Explore the biggest stocks movers on the market.
Buy GMAB.CO
Scroll to top